ORPHA:1934
Early infantile developmental and epileptic encephalopathy
Also known as: EIDEE · Early infantile epileptic encephalopathy with suppression-bursts · Ohtahara syndrome
Publications
7,365
Trials
2
Interventional, condition-specific
Researchers
1,329
Distinct authors in sample
Gene link
—
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
A severe form of age-related epileptic encephalopathies characterized by the onset of tonic spasms within the first 3 months of life that can be generalized or lateralized, independent of the sleep cycle, and that can occur hundreds of times per day, leading to psychomotor impairment and death.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0800491
- UMLS:C0393706
- NCIT:C116593
Additional Mondo synonyms (10)
EIEE · EME · early infantile epileptic encephalopathy · early infantile epileptic encephalopathy with suppression-bursts · early myoclonic encephalopathy · early myoclonic encephalopathy with suppression-bursts · early-infantile developmental and epileptic encephalopathy syndrome · epileptic encephalopathy, early infantile · epileptic encephalopathy, infantile · infantile epileptic encephalopathy
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
7,365 matched papers (5,667 in last 10 years) Source
- Phenotype characterisedPresent
118 HPO annotations (e.g. Focal motor seizure; Epileptic encephalopathy; Lethargy) Source
- Animal modelPresent
13 genotype models (Mus musculus, Danio rerio) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
2 matched on ClinicalTrials.gov (1 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
118
Associated phenotypes · MONDO:0800491
- Focal motor seizure
- Epileptic encephalopathy
- Lethargy
- Hyperreflexia
- Recurrent respiratory infections
Showing 5 of 118 — open Monarch for the full list.
Animal models (Monarch / Alliance)
13
Model associations linked to this Mondo ID
- Arxtm1Gldn/Y Tg(mI56i-cre,-EGFP)1Kc/0 [background:] involves: 129/Sv * C57BL/6 * CD-1 * FVB/N·MGI:3844352·Mus musculus
- stxbp1bs3001/s3001 (WIK)·ZFIN:ZDB-FISH-150901-7106·Danio rerio
- Arxtm1Gldn/Arx+ Tg(mI56i-cre,-EGFP)1Kc/0 [background:] involves: 129/Sv * C57BL/6 * CD-1 * FVB/N·MGI:3844353·Mus musculus
- WT + MO1-got2a·ZFIN:ZDB-FISH-200714-15·Danio rerio
- slc1a2bzh7/zh7·ZFIN:ZDB-FISH-230830-9·Danio rerio
- Arxtm4Kki/Y [background:] involves: 129S/SvEv * C57BL/6NHsd·MGI:6196032·Mus musculus
- Got2em3Pcamp/Got2em3Pcamp [background:] involves: C57BL/6·MGI:7464550·Mus musculus
- Arxtm5Kki/Y [background:] involves: 129S/SvEv * C57BL/6NHsd·MGI:6196031·Mus musculus
- Arxtm1.1Ics/Y [background:] involves: 129S2/SvPas * C57BL/6J * C57BL/6N·MGI:6195853·Mus musculus
- Arxtm4Kki/Y [background:] involves: 129S/SvEv * C57BL/6J·MGI:4359207·Mus musculus
- Arxtm1.1Jno/Y [background:] involves: 129S7/SvEvBrd * C57BL/6J·MGI:4353223·Mus musculus
- Scn8aem1Mm/Scn8a+ [background:] involves: C57BL/6J * SJL·MGI:5578216·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
2
Drugs / clinical candidates · MONDO_0800491
- LEVETIRACETAM·phase 3
- ZONISAMIDE·phase 3
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
7,365
7,365 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
7,365 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
5,667 in the last 10 years · low confidence
Phrase hits: 7,365 · MeSH hits: 0
Who's working on it?
1,329
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Bai Y4 papers · 2026
Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, The College of Life Sciences, Northwest University, Xi'an 710069, P.R. China.
Papers in Europe PMC - 02Perry MS4 papers · 2026
Cook Children's Medical Center, Fort Worth, TX, USA. Electronic address: Scott.Perry@cookchildrens.org.
Papers in Europe PMC - 03Riva A4 papers · 2026
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
Papers in Europe PMC - 04Striano P4 papers · 2026
Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
Papers in Europe PMC - 05Aledo-Serrano A3 papers · 2026
Epilepsy Unit, Clinical Neuroscience Institute, Vithas Madrid University Hospitals, Madrid, Spain.
Papers in Europe PMC - 06Battaglia DI3 papers · 2026
Dipartimento della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Roma, Italy; Department of Health Science and Public Health, Università Cattolica del Sacro Cuore, Italy. Electronic address: domenicaimmacolata.battaglia@policlinicogemelli.it.
Papers in Europe PMC - 07Chen C3 papers · 2026
Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Papers in Europe PMC - 08Goldberg EM3 papers · 2026
Division of Neurology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Papers in Europe PMC - 09
- 10Hood V3 papers · 2026
Epilepsy Division, Dravet Syndrome Foundation, Cherry Hill, New Jersey.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
2
interventional trials for this specific condition
2 interventional trials matched this specific condition name; 1 currently recruiting in our sample. 14 trials are registered for developmental and epileptic encephalopathy, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
2 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 84.5th percentile).
low confidence · 84.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
2 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06938542·ENROLLING BY INVITATION·Palliative Care Needs of Children With Rare Diseases and Their Families
Not reviewed·Conditions: Trisomy 13 Syndrome · Arthrogryposis Congenita Multiplex With Intestinal Atresia · Asparagine Synthetase Deficiency · CHARGE Syndrome·Matched via name phrase
Broader category: developmental and epileptic encephalopathy
14
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07010471·RECRUITING·A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine
Not reviewed·Conditions: Developmental and Epileptic Encephalopathy 1·Matched via name phrase
- NCT05737784·RECRUITING·A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy
Not reviewed·Conditions: SCN2A-DEE · Epilepsy·Matched via name phrase
- NCT07723976·NOT YET RECRUITING·A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE
Not reviewed·Conditions: Developmental and Epileptic Encephalopathy (DEE)·Matched via name phrase
- NCT07227857·RECRUITING·A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy
Not reviewed·Conditions: Epileptic Encephalopathy·Matched via name phrase
- NCT06908226·ENROLLING BY INVITATION·A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
Not reviewed·Conditions: Developmental and Epileptic Encephalopathy·Matched via name phrase
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT07585643·NOT YET RECRUITING·IBIS - Investigating Reliability of BIS and SEDLINE Monitoring in Children With Developmental and Epileptic Encephalopathies (DEE).
Not reviewed·Conditions: Epileptic Encephalopathy · Early Infantile Epileptic Encephalopathy · Infantile Spasm · Developmental and Epileptic Encephalopathies·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Early infantile developmental and epileptic encephalopathy — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Early infantile developmental and epileptic encephalopathy" OR "EIDEE" OR "Early infantile epileptic encephalopathy with suppression-bursts" OR "Ohtahara syndrome" OR "early infantile epileptic encephalopathy" OR "early myoclonic encephalopathy" OR "early myoclonic encephalopathy with suppression-bursts" OR "early-infantile developmental and epileptic encephalopathy syndrome" OR "epileptic encephalopathy, early infantile" OR "epileptic encephalopathy, infantile" OR "infantile epileptic encephalopathy"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Early infantile developmental and epileptic encephalopathy" OR "EIDEE" OR "Early infantile epileptic encephalopathy with suppression-bursts" OR "Ohtahara syndrome" OR "early infantile epileptic encephalopathy" OR "early myoclonic encephalopathy" OR "early myoclonic encephalopathy with suppression-bursts" OR "early-infantile developmental and epileptic encephalopathy syndrome" OR "epileptic encephalopathy, early infantile" OR "epileptic encephalopathy, infantile" OR "infantile epileptic encephalopathy"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 2 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"developmental and epileptic encephalopathy"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: EIEE; EME
Confidence reasoning
- Preferred label is multi-word and distinctive
- 2 synonym(s) dropped by stoplist (may under-count)
- "early myoclonic encephalopathy" also appears on ORPHA:1935
- "early myoclonic encephalopathy with suppression-bursts" also appears on ORPHA:1935
Ingested 2026-07-26T18:33:12.367Z
